FibroBiologics, Inc. Common Stock (FBLG NASDAQ) stock market data APIs
$0.2515
-0.02(-8%)
as of February 6, 2026
Try our APIs with
free plan!
FibroBiologics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.
Prev. Close
0.2515
Open
0.2338
High
0.2655
Low
0.2332
52 wk Range
0.22-1.98
Market Cap
16 743 K
Shares Outstanding
66 520 K
EPS
-0.13
Beta
-0.578
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with FibroBiologics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get FibroBiologics, Inc. Common Stock data using free add-ons & libraries
Get FibroBiologics, Inc. Common Stock Fundamental Data
FibroBiologics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -17 546 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-31
- EPS/Forecast: -0.115
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
FibroBiologics, Inc. Common Stock News
New
FibroBiologics to Present at the DealFlow Discovery Conference
HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the...
After-Hours Biotech Rally: FBLG, NYXH, FBIO, RVTY, OPCH, ATNM, DSGN Climb On Earnings And Momentum
(RTTNews) - Several biotech and healthcare names posted notable gains in Monday's after-hours trading session, with moves driven by earnings updates, guidance announcements, and broader investor senti...
FibroBiologics announces payoff of outstanding debt
* FibroBiologics (FBLG [https://seekingalpha.com/symbol/FBLG]) said on Wednesday that it has paid all amounts outstanding [https://seekingalpha.com/pr/20321143-fibrobiologics-announces-payoff-of-out...
FibroBiologics Announces Payoff of Outstanding Debt
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pendin...
Get FibroBiologics, Inc. Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
